Federation des caisses Desjardins du Quebec’s Cytokinetics CYTK Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$754K	Buy	8,854 +1,306	+17%	+$93.8K	﹤0.01%	1211
2026 Q1	$497K	Buy	7,548 +7,353	+3,771%	+$467K	﹤0.01%	1266
2025 Q4	$12.4K	Hold	195	–	–	﹤0.01%	2189
2025 Q3	$10.7K	Hold	195	–	–	﹤0.01%	2240
2025 Q2	$6.44K	Hold	195	–	–	﹤0.01%	2193
2025 Q1	$7.84K	Hold	195	–	–	﹤0.01%	2035
2024 Q4	$9.17K	Hold	195	–	–	﹤0.01%	1908
2024 Q3	$10.3K	Hold	195	–	–	﹤0.01%	1869
2024 Q2	$10.6K	Hold	195	–	–	﹤0.01%	1799
2024 Q1	$13.7K	Hold	195	–	–	﹤0.01%	1744
2023 Q4	$16.3K	Hold	195	–	–	﹤0.01%	1635
2023 Q3	$5.75K	Hold	195	–	–	﹤0.01%	1884
2023 Q2	$6.36K	Hold	195	–	–	﹤0.01%	1858
2023 Q1	$6.86K	Hold	195	–	–	﹤0.01%	1844
2022 Q4	$8.94K	Hold	195	–	–	﹤0.01%	1905
2022 Q3	$9.45K	Hold	195	–	–	﹤0.01%	1932
2022 Q2	$7.66K	Hold	195	–	–	﹤0.01%	2019
2022 Q1	$7.18K	Hold	195	–	–	﹤0.01%	2118
2021 Q4	$8.89K	Sell	195 -200	-51%	-$7.72K	﹤0.01%	2056
2021 Q3	$14.1K	Buy	395 +200	+103%	+$5.89K	﹤0.01%	1958
2021 Q2	$3.86K	Buy	+195	New	+$4.58K	﹤0.01%	2316
2020 Q1	–	Sell	-400	Closed	-$4.24K	–	2258
2019 Q4	$4.24K	Hold	400	–	–	﹤0.01%	2054
2019 Q3	$4.55K	Hold	400	–	–	﹤0.01%	1978
2019 Q2	$4.5K	Hold	400	–	–	﹤0.01%	2007
2019 Q1	$3.24K	Hold	400	–	–	﹤0.01%	1875
2018 Q4	$2.53K	Hold	400	–	–	﹤0.01%	1888
2018 Q3	$3.94K	Hold	400	–	–	﹤0.01%	1923
2018 Q2	$3.32K	Hold	400	–	–	﹤0.01%	1967
2018 Q1	$2.88K	Hold	400	–	–	﹤0.01%	1961
2017 Q4	$3.26K	Sell	400 -4,773	-92%	-$54.2K	﹤0.01%	1941
2017 Q3	$75.2K	Buy	5,173 +40	+0.8%	+$546	﹤0.01%	1227
2017 Q2	$62.1K	Hold	5,133	–	–	﹤0.01%	1334
2017 Q1	$66K	Buy	+5,133	New	+$60K	﹤0.01%	1100

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CYTK Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Cytokinetics (CYTK) stake by 17% in Q2 2026, buying an estimated $93.8K and bringing the position to 8,854 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Federation des caisses Desjardins du Quebec first reported a position in CYTK in Q1 2017 and has held it in 33 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Federation des caisses Desjardins du Quebec held 8,854 shares of Cytokinetics worth $754K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 1,306 Cytokinetics shares in Q2 2026, an estimated $93.8K.
Cytokinetics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1211 holding.
Federation des caisses Desjardins du Quebec first reported a position in Cytokinetics in Q1 2017 and has held it in 33 quarters since.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.